According to the report, "dr.(b)(6) placed a left arm hero graft at community south on (b)(6) 2015.Patient clotted and he and dr.(b)(6) had to do a revision today with a 40 cm procol graft.They exposed the axillary and then cut down and ligated the existing avg at the brachial anastomosis.Used a 4 fogarty and made several passes throughout the entire hero graft to declot the graft.Connected the two grafts end-to-end near the brachial artery.Confirmed patency and closed." the hospital was unable to provide the lot number of the hero arterial graft component implanted on (b)(6) 2015.Shipping records were queried and lots h14av027 and h15av003 were identified as having been shipped to the hospital in the six months prior to the implant.The manufacturing records for lots h14av027 and h15av003 were reviewed and it was confirmed that all records were controlled, available for review, and met all specifications per the device master record.A review was performed of the available information.The patient was implanted with a hero graft in early (b)(6) 2015.In early (b)(6) 2015, the patient clotted.Partial stenosis or full occlusion of prosthesis or vasculature is listed on the hero instructions for use (ifu) as a potential vascular graft and catheter complication.In this case, the surgeon chose to treat the clot with a graft revision using a 40cm procol graft.The procol graft was attached end-to-end with the arterial graft component near the brachial artery.Before the connection, the surgeon used a "4 fogarty" to declot the entire hero graft.At the end of the procedure patency was confirmed.The ifu lists vascular graft revision/replacement as a potential treatment for vascular graft and catheter complication.Patient medical history was not provided and therefore the risk of clots due to patient characteristics cannot be assessed.An increased risk for graft thrombosis could be caused by a hypercoagulability state or impaired blood flow through the graft.Precautions regarding inadequate anticoagulation are provided in the hero ifu.Operative notes were also unavailable and it cannot be determined if there were any deviations from the suggested implantation methodology.It is also unclear why the surgeon chose to revise the agc with a procol graft.At this time, the role of the hero graft in the aforementioned clotting cannot be determined.The ifu lists the following potential complications with the use of the hero graft: vascular graft revision/replacement and partial stenosis or full occlusion of prosthesis or vasculature.
|